Studies Old

Our Current Studies

If you are interested in any of these studies, call one of our trained staff to discuss today at 704-817-7732.

...Provide Hope for the Future of Medicine.

Alzheimer’s Disease #1

Phase 2a Feasibility Study of study drug in subjects with Mild- to-Moderate Alzheimer’s Disease

Read More

Alzheimer’s Disease #2

This study focuses on Alzheimer’s treatment rather than prevention.

Read More

Schizophrenia 1-Cognition

A Randomized, Double-blind, Placebo-controlled, Parallel, 26-Week, Phase 3 Study of 2 Doses of an Alpha-7 Nicotinic Acetylcholine Receptor Agonist study drug or Placebo as an Adjunctive Pro-cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapy

Schizophrenia 2 - First Onset

A Prospective, Matched-Control, Randomized, Open-Label, Flexible-Dose, Study in Subjects with Recent-Onset Schizophrenia or Schizophreniform Disorder to Compare Disease Progression and Disease Modification Following Treatment with Paliperidone Palmitate Long-Acting Injection or Oral Antipsychotics

Schizophrenia 3 - Treatment Resistance

Interventional, randomized, double-blind, active-controlled, fixed-dose study of study drug in patients with treatment-resistant schizophrenia

Schizophrenia 4

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of Study drug as a Treatment in Subjects with Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)

Schizophrenia 5

A phase II randomized, double-blinded, placebo-controlled parallel group trial to examine the efficacy and safety of 4 oral doses of study drug once daily over 12 week treatment period in patients with Schizophrenia and the effect on cognition and function in schizophrenia.


Forest Lab -- Coming soon

Major Depression 1

A Phase 3 Multicenter Study of the Long-term Safety and Tolerability of study drug for the Adjunctive Treatment of Major Depressive Disorder in Adults who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)

Major Depression 2

A Non-Interventional Study of Subjects using study drug, a Study of Adjunctive Treatment of Major Depressive Disorder

Major Depression 3

A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With study drug ER in Patients With Major Depressive Disorder


Coming Soon

Ready to find out more? Get started today!